I will quickly go to you, Mr. Williams.
You have a very interesting background from your experience with Innovation Canada, with Research Canada and with a political career.
I don't have time to go over the preamble but, in this bill, we talk about supporting modernization of the health care system with drug data and improving coordination. We talk about the national strategy for rare diseases.
Is there room for improving collaboration and innovation within the context of Bill C-64? Do you see that there is potential there?